Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Methods for high-dimensonal analysis of cells dissociated from cyropreserved synovial tissue.

Donlin LT, Rao DA, Wei K, Slowikowski K, McGeachy MJ, Turner JD, Meednu N, Mizoguchi F, Gutierrez-Arcelus M, Lieb DJ, Keegan J, Muskat K, Hillman J, Rozo C, Ricker E, Eisenhaure TM, Li S, Browne EP, Chicoine A, Sutherby D, Noma A; Accelerating Medicines Partnership RA/SLE Network, Nusbaum C, Kelly S, Pernis AB, Ivashkiv LB, Goodman SM, Robinson WH, Utz PJ, Lederer JA, Gravallese EM, Boyce BF, Hacohen N, Pitzalis C, Gregersen PK, Firestein GS, Raychaudhuri S, Moreland LW, Holers VM, Bykerk VP, Filer A, Boyle DL, Brenner MB, Anolik JH.

Arthritis Res Ther. 2018 Jul 11;20(1):139. doi: 10.1186/s13075-018-1631-y.

2.

Interleukin-23 as a therapeutic target for inflammatory myopathy.

Umezawa N, Kawahata K, Mizoguchi F, Kimura N, Yoshihashi-Nakazato Y, Miyasaka N, Kohsaka H.

Sci Rep. 2018 Apr 3;8(1):5498. doi: 10.1038/s41598-018-23539-4.

3.

Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis.

Mizoguchi F, Slowikowski K, Wei K, Marshall JL, Rao DA, Chang SK, Nguyen HN, Noss EH, Turner JD, Earp BE, Blazar PE, Wright J, Simmons BP, Donlin LT, Kalliolias GD, Goodman SM, Bykerk VP, Ivashkiv LB, Lederer JA, Hacohen N, Nigrovic PA, Filer A, Buckley CD, Raychaudhuri S, Brenner MB.

Nat Commun. 2018 Feb 23;9(1):789. doi: 10.1038/s41467-018-02892-y.

4.

National survey of hospital child protection teams in Japan.

Tanoue K, Senda M, An B, Tasaki M, Taguchi M, Kobashi K, Oana S, Mizoguchi F, Shiraishi Y, Yamada F, Okuyama M, Ichikawa K.

Child Abuse Negl. 2018 May;79:11-21. doi: 10.1016/j.chiabu.2018.01.016. Epub 2018 Feb 6.

PMID:
29407852
5.

Hemophagocytic Syndrome Complicated with Dermatomyositis Controlled Successfully with Infliximab and Conventional Therapies.

Komiya Y, Saito T, Mizoguchi F, Kohsaka H.

Intern Med. 2017;56(23):3237-3241. doi: 10.2169/internalmedicine.7966-16. Epub 2017 Dec 1.

6.

Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes.

Chang SK, Kohlgruber AC, Mizoguchi F, Michelet X, Wolf BJ, Wei K, Lee PY, Lynch L, Duquette D, Ceperuelo-Mallafré V, Banks AS, Brenner MB.

J Clin Invest. 2017 Sep 1;127(9):3300-3312. doi: 10.1172/JCI86881. Epub 2017 Jul 31.

7.

A Comparative Study between Universal Eclectic Septoplasty Technique and Cottle.

Amaral Neto OFD, Mizoguchi FM, Freitas RDS, Maniglia JJ, Maniglia FF, Maniglia RF.

Int Arch Otorhinolaryngol. 2017 Jul;21(3):281-285. doi: 10.1055/s-0037-1599275. Epub 2017 Mar 22.

8.

Training program for Japanese medical personnel to combat child maltreatment.

Tanoue K, Senda M, An B, Tasaki M, Taguchi M, Kobashi K, Oana S, Mizoguchi F, Shiraishi Y, Yamada F, Okuyama M, Ichikawa K.

Pediatr Int. 2017 Jul;59(7):764-768. doi: 10.1111/ped.13278. Epub 2017 Jun 9.

PMID:
28295898
9.

Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators.

Nguyen HN, Noss EH, Mizoguchi F, Huppertz C, Wei KS, Watts GFM, Brenner MB.

Immunity. 2017 Feb 21;46(2):220-232. doi: 10.1016/j.immuni.2017.01.004.

10.

Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis.

Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, Donlin LT, Henderson LA, Wei K, Mizoguchi F, Teslovich NC, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Lee YC, Todd DJ, Bykerk VP, Goodman SM, Pernis AB, Ivashkiv LB, Karlson EW, Nigrovic PA, Filer A, Buckley CD, Lederer JA, Raychaudhuri S, Brenner MB.

Nature. 2017 Feb 1;542(7639):110-114. doi: 10.1038/nature20810.

11.

Direct suppression of autoaggressive CD8+ T cells with CD80/86 blockade in CD8+ T cell-mediated polymyositis models of mice.

Hasegawa H, Kawahata K, Mizoguchi F, Okiyama N, Miyasaka N, Kohsaka H.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):593-597. Epub 2017 Jan 27.

PMID:
28134083
12.

NFAT restricts osteochondroma formation from entheseal progenitors.

Ge X, Tsang K, He L, Garcia RA, Ermann J, Mizoguchi F, Zhang M, Zhou B, Zhou B, Aliprantis AO.

JCI Insight. 2016 Apr;1(4):e86254.

13.

Tacrolimus successfully used to control refractory eosinophilic granulomatosis with polyangiitis complicated by invasive aspergillosis and chronic hepatitis B.

Hirano F, Mizoguchi F, Harigai M, Miyasaka N, Kohsaka H.

Int J Rheum Dis. 2019 Apr;22(4):746-749. doi: 10.1111/1756-185X.12869. Epub 2016 Apr 29.

PMID:
27125472
14.

Local fibroblast proliferation but not influx is responsible for synovial hyperplasia in a murine model of rheumatoid arthritis.

Matsuo Y, Mizoguchi F, Saito T, Kawahata K, Ueha S, Matsushima K, Inagaki Y, Miyasaka N, Kohsaka H.

Biochem Biophys Res Commun. 2016 Feb 12;470(3):504-509. doi: 10.1016/j.bbrc.2016.01.121. Epub 2016 Jan 22.

PMID:
26806309
15.

A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.

Hosoya T, Mizoguchi F, Hasegawa H, Miura K, Koike R, Kubota T, Miyasaka N, Kohsaka H.

Intern Med. 2015;54(16):2069-72. doi: 10.2169/internalmedicine.54.3371. Epub 2015 Aug 15.

16.

A case of relapsing polychondritis initially presenting with bronchial chondritis.

Nakazato Y, Mizoguchi F, Kohsaka H, Miyasaka N.

Mod Rheumatol. 2014 Nov;24(6):1019-22. doi: 10.3109/14397595.2013.874746. Epub 2014 Feb 11.

PMID:
24517556
17.

A case of dermatomyositis with rhabdomyolysis, rescued by intravenous immunoglobulin.

Mizoguchi F, Takada K, Ishikawa K, Mizusawa H, Kohsaka H, Miyasaka N.

Mod Rheumatol. 2015 Jul;25(4):646-8. doi: 10.3109/14397595.2013.843753. Epub 2013 Nov 5.

PMID:
24252047
18.

miR-31 controls osteoclast formation and bone resorption by targeting RhoA.

Mizoguchi F, Murakami Y, Saito T, Miyasaka N, Kohsaka H.

Arthritis Res Ther. 2013;15(5):R102.

19.

Characteristics of polypoid lesions in patients undergoing microsurgery of the larynx.

Filho JM, Carvalho B, Mizoguchi FM, Catani GS, Filho ED, Malafaia O, Stahlke HJ Jr.

Int Arch Otorhinolaryngol. 2013 Jul;17(3):279-84. doi: 10.7162/S1809-97772013000300008.

20.

Systemic lupus erythematosus with cytophagic histiocytic panniculitis successfully treated with high-dose glucocorticoids and cyclosporine A.

Hasegawa H, Mizoguchi F, Kohsaka H, Miyasaka N.

Lupus. 2013 Mar;22(3):316-9. doi: 10.1177/0961203313476355.

PMID:
23439471
21.

Tocilizumab-induced immune complex glomerulonephritis in a patient with rheumatoid arthritis.

Matsuo Y, Mizoguchi F, Kohsaka H, Ito E, Eishi Y, Miyasaka N.

Rheumatology (Oxford). 2013 Jul;52(7):1341-3. doi: 10.1093/rheumatology/kes403. Epub 2013 Jan 15. No abstract available.

PMID:
23325036
22.

Osteoblastic differentiation enhances expression of TRPV4 that is required for calcium oscillation induced by mechanical force.

Suzuki T, Notomi T, Miyajima D, Mizoguchi F, Hayata T, Nakamoto T, Hanyu R, Kamolratanakul P, Mizuno A, Suzuki M, Ezura Y, Izumi Y, Noda M.

Bone. 2013 May;54(1):172-8. doi: 10.1016/j.bone.2013.01.001. Epub 2013 Jan 11.

PMID:
23314072
23.

p16(INK4a) exerts an anti-inflammatory effect through accelerated IRAK1 degradation in macrophages.

Murakami Y, Mizoguchi F, Saito T, Miyasaka N, Kohsaka H.

J Immunol. 2012 Nov 15;189(10):5066-72. doi: 10.4049/jimmunol.1103156. Epub 2012 Oct 12.

24.

[Role of microRNA in rheumatoid arthritis].

Mizoguchi F, Kohsaka H.

Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(1):69-74. Review. Japanese.

25.

Type VI collagen deficiency induces osteopenia with distortion of osteoblastic cell morphology.

Izu Y, Ezura Y, Mizoguchi F, Kawamata A, Nakamoto T, Nakashima K, Hayata T, Hemmi H, Bonaldo P, Noda M.

Tissue Cell. 2012 Feb;44(1):1-6. doi: 10.1016/j.tice.2011.08.002. Epub 2011 Nov 8.

PMID:
22071216
26.

[Control of bone remodeling by nervous system. Nervous system and bone].

Noda M, Nagao M, Hanyu R, Mizoguchi F, Notomi T, Hayata T, Nakamoto T, Ezura Y.

Clin Calcium. 2010 Dec;20(12):1801-5. doi: CliCa101218011805. Review. Japanese.

PMID:
21123931
27.

Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis.

Kaneko K, Nanki T, Hosoya T, Mizoguchi F, Miyasaka N.

Mod Rheumatol. 2010 Dec;20(6):632-6. doi: 10.1007/s10165-010-0333-3. Epub 2010 Jul 9.

PMID:
20617355
28.

Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.

Mizoguchi F, Izu Y, Hayata T, Hemmi H, Nakashima K, Nakamura T, Kato S, Miyasaka N, Ezura Y, Noda M.

J Cell Biochem. 2010 Apr 1;109(5):866-75. doi: 10.1002/jcb.22228.

PMID:
20039311
29.

Combinatory effects of androgen receptor deficiency and hind limb unloading on bone.

Saita Y, Nakamura T, Mizoguchi F, Nakashima K, Hemmi H, Hayata T, Ezura Y, Kurosawa H, Kato S, Noda M.

Horm Metab Res. 2009 Nov;41(11):822-8. doi: 10.1055/s-0029-1231056. Epub 2009 Jul 23.

PMID:
19629928
30.

Hypoxia-induced abrogation of contact-dependent inhibition of rheumatoid arthritis synovial fibroblast proliferation.

Nonomura Y, Mizoguchi F, Suzuki A, Nanki T, Kato H, Miyasaka N, Kohsaka H.

J Rheumatol. 2009 Apr;36(4):698-705. doi: 10.3899/jrheum.080188. Epub 2009 Feb 17.

PMID:
19228663
31.

Angiotensin II type 2 receptor blockade increases bone mass.

Izu Y, Mizoguchi F, Kawamata A, Hayata T, Nakamoto T, Nakashima K, Inagami T, Ezura Y, Noda M.

J Biol Chem. 2009 Feb 20;284(8):4857-64. doi: 10.1074/jbc.M807610200. Epub 2008 Nov 11.

32.

Pneumatosis cystoides intestinalis following lupus enteritis and peritonitis.

Mizoguchi F, Nanki T, Miyasaka N.

Intern Med. 2008;47(13):1267-71. Epub 2008 Jul 1.

33.

Varicella-zoster virus hepatitis in polymyositis.

Mizoguchi F, Nakamura S, Iwai H, Kubota T, Miyasaka N.

Mod Rheumatol. 2008;18(3):301-5. doi: 10.1007/s10165-008-0049-9. Epub 2008 Mar 25.

PMID:
18360803
34.

Recurrent pulmonary embolism due to intracardiac thrombi in systemic sclerosis.

Mizoguchi F, Nanki T, Takada K, Miyasaka N.

Clin Exp Rheumatol. 2008 Jan-Feb;26(1):157. No abstract available.

PMID:
18328167
35.

Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss.

Mizoguchi F, Mizuno A, Hayata T, Nakashima K, Heller S, Ushida T, Sokabe M, Miyasaka N, Suzuki M, Ezura Y, Noda M.

J Cell Physiol. 2008 Jul;216(1):47-53. doi: 10.1002/jcp.21374.

PMID:
18264976
36.
37.

[Clinical evaluation for radiotherapy of metastatic brain tumors in lung cancer: prognostic analyses relevant to QOL].

Myojin M, Nishio M, Mizoguchi F, Kawashima K, Mita N, Fujita A.

Gan To Kagaku Ryoho. 1998 Jan;25(1):43-51. Japanese.

PMID:
9464328
38.

[Pharmacokinetic and clinical studies on cefmenoxime in neonates and infants].

Iwai N, Shibata M, Mizoguchi F, Nakamura H, Katayama M, Taneda Y, Inokuma K, Ozaki T, Ichikawa T, Matsui S, et al.

Jpn J Antibiot. 1989 Dec;42(12):2641-60. Japanese.

PMID:
2614919
39.

[Pharmacokinetics in neonates and infants following administration of amikacin].

Iwai N, Sasaki A, Taneda Y, Mizoguchi F, Nakamura H, Kawamura M, Tauchi N, Ozaki T, Ichikawa T, Matsui S.

Jpn J Antibiot. 1987 Jun;40(6):1157-75. Japanese.

PMID:
3669298
40.

[Study on the use of cefotiam in neonates].

Iwai N, Taneda Y, Shibata M, Mizoguchi F, Nakamura H, Katayama M, Tauchi N, Kawamura M, Ozaki T, Ichikawa T, et al.

Jpn J Antibiot. 1986 Sep;39(9):2436-49. Japanese.

PMID:
3467085
41.

[Fundamental and clinical evaluations of ceftazidime in neonates].

Iwai N, Shibata M, Mizoguchi F, Nakamura H, Katayama M, Taneda Y, Inokuma K.

Jpn J Antibiot. 1986 Aug;39(8):2142-54. Japanese.

PMID:
3540346
42.

[Fundamental and clinical studies on cefixime in pediatrics].

Iwai N, Shibata M, Mizoguchi F, Nakamura H, Katayama M.

Jpn J Antibiot. 1986 Apr;39(4):1087-105. Japanese.

PMID:
3761539
43.

[Fundamental and clinical studies on aztreonam in the pediatric field].

Iwai N, Taneda Y, Shibata M, Mizoguchi F, Nakamura H, Katayama M.

Jpn J Antibiot. 1985 Nov;38(11):3273-84. Japanese.

PMID:
4094059
44.

[Clinical studies of ceftizoxime suppositories in respiratory tract infections and urinary tract infections in children].

Iwai N, Taneda Y, Shibata M, Mizoguchi F, Nakamura H, Katayama M.

Jpn J Antibiot. 1985 Oct;38(10):2903-16. Japanese.

PMID:
3866084
45.

[Fundamental and clinical studies on aspoxicillin in the pediatric field].

Iwai N, Taneda Y, Shibata M, Mizoguchi F, Nakamura H, Katayama M.

Jpn J Antibiot. 1985 Jul;38(7):1868-81. Japanese.

PMID:
3851860
46.

[Fundamental and clinical studies on cefminox in the field of pediatrics].

Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M.

Jpn J Antibiot. 1985 Mar;38(3):705-19. Japanese.

PMID:
3897604
47.

[Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].

Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M.

Jpn J Antibiot. 1985 Feb;38(2):342-58. Japanese.

PMID:
3847522
48.

[Fundamental and clinical evaluation of ceftriaxone in the pediatric field].

Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M.

Jpn J Antibiot. 1984 Nov;37(11):2111-30. Japanese.

PMID:
6098705
49.

[Studies on sulbactam/cefoperazone in the field of pediatrics].

Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M.

Jpn J Antibiot. 1984 Oct;37(10):1859-79. Japanese.

PMID:
6094865
50.

[Fundamental and clinical studies on ceftazidime in the field of pediatrics].

Iwai N, Sasaki A, Taneda Y, Shibata M, Mizoguchi F, Nakamura H.

Jpn J Antibiot. 1984 Mar;37(3):490-511. Japanese.

PMID:
6376858

Supplemental Content

Loading ...
Support Center